Starting semaglutide or tirzepatide without bloodwork is a gamble. Here are the tests that matter before and during GLP-1 treatment — and what MDLink Diagnostic Laboratory's Basic and Full GLP-1 Monitoring Panels cover.
GLP-1 medications like semaglutide and tirzepatide have reached the Caribbean. Here's how they work, what results are realistic, what they cost, and why online medical care is the safest way to start.
Ask around at any office lunch in Kingston, Port of Spain or Bridgetown and someone knows someone on "the injection." A cousin who dropped four dress sizes before a wedding. A boss who quietly stopped ordering the second plate. A friend of a friend who bought vials from a man on Instagram and spent three days vomiting.
That is where the Caribbean is right now with GLP-1 medications: enormous demand, patchy information, and almost no structured medical care around the drug itself.
This post is an attempt to fix the information part.
First, the uncomfortable numbers
The Caribbean is one of the heaviest regions on earth, and we have been heading in this direction for forty years.
In Jamaica, adult overweight and obesity climbed from roughly 44% of adults in 2000 to over 55% by 2016, and obesity alone has kept rising since. Roughly one in three Jamaican women live with obesity. Diabetes affects an estimated 17% of adult women here. In Trinidad and Tobago, close to 30% of adult women and 13% of adult men live with obesity, with diabetes at about 16% and 14% respectively. The Bahamas, St Kitts and Nevis and Barbados all sit near or above 40% adult obesity.
Modelling work using Jamaica as a test case projects adult diabetes rising from 12% in 2018 to around 21% by 2050 if nothing changes, with obesity heading toward 39%.
These are not vanity statistics. They are the reason our emergency rooms fill with strokes, our dialysis units run at capacity, and Caribbean families budget for amputations.
So when a class of medication arrives that reliably produces 15–20% body weight loss and cuts cardiovascular events, it matters here more than almost anywhere.
What GLP-1s actually are
GLP-1 is a hormone your own gut releases after you eat. It tells your pancreas to release insulin, slows how quickly your stomach empties, and signals your brain that you have had enough.
GLP-1 medications are engineered versions of that hormone that last a week instead of minutes. The practical effect people describe is the quieting of what patients call "food noise" — the constant background negotiation about the next meal.
The main options you will hear about:
- Semaglutide (Ozempic, Wegovy) — weekly injection. Around 15% average body weight loss in trials.
- Tirzepatide (Mounjaro, Zepbound) — weekly injection, works on two receptors instead of one. Around 20–21% average loss at the top dose, the strongest of the currently available options.
- Oral semaglutide (the Wegovy pill, 25 mg) — approved in the US in December 2025 and launched in January 2026, the first pill approved specifically for weight management. Trial results were in the 13–17% range depending on adherence. It must be taken on an empty stomach with a small amount of water.
- Orforglipron (Foundayo) — a non-peptide daily pill approved in 2026 with no food-timing restriction, around 11% weight loss. Less powerful, far more convenient.
- Liraglutide (Saxenda, Victoza) — the older daily injection. Now available as a generic, which makes it cheaper, but it delivers roughly 5–8% and has largely been overtaken.
In 2025 the World Health Organization added semaglutide and tirzepatide to its Essential Medicines List for adults, while pointedly urging cheaper generic supply for lower and middle income countries. That second half of the sentence is the Caribbean's whole problem.
The Caribbean access gap
Four things make GLP-1 access here different from Miami or London.
1. Cost, with no insurance backstop. Brand-name pens landed in the region carry importer margins on top of an already high manufacturer price. Most Caribbean health plans do not classify obesity as a disease, so they will not fund the medication for weight loss. Patients pay cash.
2. Almost no obesity medicine specialists. There are very few clinicians in the region whose primary practice is metabolic and weight management. Most patients end up with a five-minute conversation appended to an unrelated appointment.
3. Geography. If you live in Portland, Mandeville, Sangre Grande or on a smaller island entirely, "monthly follow-up with a doctor" can mean two hours of travel and a lost day of work. Titrating a medication that needs monthly dose decisions becomes impossible.
4. A thriving grey market. Unlabelled vials sold over WhatsApp. Reconstitution instructions from a TikTok. Pens bought in a suitcase in Miami and carried home in hand luggage at room temperature for eight hours. Every doctor in the region has now seen the results of this.
Why telehealth fits this problem unusually well
Telemedicine is often oversold. For GLP-1 care it is genuinely the right tool, because of what this treatment actually requires.
GLP-1 therapy is not a procedure. It is a titration relationship. You start at a low dose, step up every four weeks, manage nausea along the way, watch for the small number of things that genuinely need stopping, and adjust. Almost all of that is conversation plus a number on a scale plus a blood test.
Conversation, weight, and labs are exactly what an online program can deliver — and deliver more often than in-person care realistically can. A patient in Trelawny can have a fifteen-minute video review every month and a WhatsApp thread for the week three nausea, without spending a dollar on transport.
What a properly run Caribbean GLP-1 telehealth program should include:
- A real medical assessment before any prescription — full history, medications, personal and family history of thyroid cancer, pancreatitis, gallbladder disease, eating disorders, pregnancy plans.
- Baseline bloodwork — at minimum HbA1c, lipid profile and thyroid function, repeated around month three. This is not upselling. It tells you whether you are treating prediabetes, and it catches thyroid disease masquerading as weight gain.
- Cold-chain medication delivery to your door, from a licensed local pharmacy. GLP-1 pens must stay refrigerated. This is the single biggest safety difference between a program and a grey-market purchase.
- Structured dose escalation with a doctor deciding each step, not a fixed schedule applied blindly.
- Side effect management included — anti-nausea prescriptions and a person to reach at 9pm on a Sunday.
- Nutrition and muscle protection. Roughly a quarter of weight lost on these drugs is lean mass. Protein targets and resistance training are not optional extras; they are the difference between getting lighter and getting healthier.
- An honest conversation about stopping. Most people regain a large share of lost weight after discontinuing. Your plan should address what happens at month twelve before you start month one.
Making it work with Caribbean food
Most GLP-1 guidance is written for an American plate, which makes it quietly useless here. A few adjustments that actually apply:
Protein first, then everything else. With a smaller appetite, whatever you eat first is what you get. Start with the fish, chicken, saltfish, red peas, lentils, eggs or curried channa — then the rice and peas, ground provisions or roti.
Carbohydrate is not the enemy, volume is. Yam, green banana, dasheen and breadfruit are fine foods. Portion them to what a reduced appetite can actually hold.
Watch the liquid calories. Sorrel, juice, sweet drinks and beer bypass the fullness signal entirely and are the most common reason a patient stalls.
Fried food will punish you. Nausea on GLP-1s is strongly linked to fat content. Fried chicken, patties, bake and doubles hit harder on treatment day than they did before.
Hydration and fibre. Constipation is extremely common and extremely fixable.
Sunday dinner is not a failure. A program that cannot survive a family Sunday is not a program that will survive a Caribbean year.
Who should not take these medications
Be direct with your doctor about all of the following, because any of them can rule you out:
- Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
- Previous pancreatitis
- Pregnancy, breastfeeding, or trying to conceive in the next few months
- Active or past eating disorder
- Severe gastroparesis or significant gastrointestinal disease
- Certain gallbladder conditions
And note: these are prescription medications with real adverse effects — pancreatitis, gallbladder disease, significant dehydration, and rare bowel obstruction among them. The nausea most people experience is manageable. The rare events are not something to navigate alone with a vial from an unverified seller.
What it costs, realistically
Cash prices vary widely by island and by supplier. As a rough regional guide in 2026:
- Brand-name pens (Mounjaro, Ozempic) bought retail in the region: the most expensive route by a wide margin
- Licensed generic and locally sourced options: substantially cheaper, and increasingly available
- Comprehensive telehealth programs bundling medication, consults, labs and support into one monthly fee: currently the most predictable way to budget for this
The bundled model exists for a reason. Once you separate out the medication, the consults, the bloodwork and the delivery, most patients underestimate the total by half and abandon treatment in month two — which is the worst possible outcome, because you paid for the hardest part and got none of the benefit.
Frequently asked questions
Do I have to be diabetic? No. These medications are prescribed for chronic weight management in adults with obesity, or with overweight plus a weight-related condition such as high blood pressure, prediabetes, fatty liver, sleep apnoea or PCOS.
How fast will I lose weight? Meaningfully slower than social media suggests. Expect the first eight weeks to be mostly dose escalation with modest change, then a steadier decline. Trial averages of 15–20% are achieved over 60 to 72 weeks, not three months.
Can I just take the pill instead? Possibly. The oral options are genuinely useful for needle-averse patients, but they are less powerful than tirzepatide and the semaglutide pill requires strict empty-stomach timing. It is a real trade-off, and worth discussing rather than assuming.
Is it safe to buy from overseas and bring it in? Legally and clinically, no. Beyond import regulations, these medications need continuous refrigeration and you have no way to verify what is in an unlabelled vial.
What happens when I stop? Most people regain a substantial portion of the weight. Obesity behaves like hypertension — treat it and it improves, stop treatment and it returns. Plan for maintenance from the start.
Will I lose muscle? Some, unavoidably. Protein intake and resistance training substantially reduce how much. Any program that does not raise this with you is not doing its job.
The bottom line
GLP-1 medications are the most effective obesity treatment ever made widely available, and they arrived in a region that needs them more than most and is least equipped to supervise them properly.
The answer is not to gatekeep the drugs. It is to wrap real medical care around them, and to deliver that care in the way Caribbean life actually allows — from your phone, in your own time, with a licensed doctor who knows your labs and answers your messages.
MDLink connects patients across the Caribbean with licensed local doctors online. Our medically guided weight loss program includes a full physician assessment, baseline and follow-up bloodwork, prescription medication delivered to your door, ongoing dose management and 24/7 support.
[Take the 3-minute assessment →]
This article is for general information and is not a substitute for individual medical advice. GLP-1 medications are prescription-only and are not suitable for everyone. Speak with a licensed doctor before starting or stopping any treatment.